The global demand for sustainable, ethical, and safe meat sources has surged in recent years, driven by concerns over environmental impact, animal welfare, and food security. Traditional livestock farming, while historically the primary means of meat production, faces significant challenges including land use, greenhouse gas emissions, resource consumption and public health risks. Advances in stem cell biology and organoid technology offer promising avenues for producing cultivated meat — in vitro cultured muscle tissue that can serve as an alternative to traditional livestock-derived meat.

Unmet Need
Despite progress in cell-based meat production, current methods face several limitations. Most cultivated meat approaches rely on primary muscle cells or myoblasts derived from a limited number of species. There remains a significant gap in scalable, reliable sources of stem cells from large mammals such as sheep and pigs, which are important for both nutritional and agricultural reasons. Furthermore, existing production approaches lack the complexity necessary to grow mature, organ-like tissues with multiple cell lineages, including muscles, connective tissues, and blood vessels, which are imperative for producing a realistic consistency and flavor profile.

Our Technology
Our innovative research demonstrates the self-organization of pluripotent stem cells from livestock species—sheep and pigs—into three-dimensional embryo models that faithfully recapitulate post-gastrulation developmental stages. These models, including gastruloids and trunk-like structures, exhibit advanced tissue differentiation, including muscle, neural, endothelial, and kidney progenitors. Utilizing extracellular matrix (ECM) components and optimized culture conditions, we induce these stem cell aggregates to develop into complex, organized tissues resembling early-stage embryonic structures capable of further maturation into muscle and other tissues relevant for cultivated meat production. This platform allows for reproducible, scalable, and species-specific tissue development, opening new possibilities for producing structured, muscle-rich tissues suitable for consumption.

Market Perspective
The cultivated meat industry is rapidly expanding, with a projected market value reaching several billion dollars in the next decade. Currently, the focus is primarily on poultry and beef, but there is a substantial niche and future demand for products derived from other large mammals like sheep and pigs, driven by preferences for specific tastes and nutritional profiles. Our technology not only addresses existing scalability and tissue complexity challenges but also broadens the scope of species-specific cultivated meat production, offering a more diverse and sustainable portfolio. This approach has significant implications for food manufacturers, agricultural biotechnology firms, and policymakers aiming to reduce environmental impacts and improve food security. Furthermore, the platform’s ability to generate multi-lineage tissues promises to deliver superior sensory qualities and nutritional content in lab-grown meat products, accelerating their acceptance in mainstream markets.

Another application of the livestock embryo-models is as a platform for studying the effects of new vererinary drugs, as well as environmental teratogens, on livestock embryonic development.

Conclusion
Harnessing the power of stem cell self-organization to develop advanced tissue models from livestock species provides a pivotal step toward realizing scalable, species-specific cultivated meat. By bridging biological complexity with technological scalability, this platform holds the potential to transform the future of meat production—making it more sustainable, ethical, and efficient.